Anesthetic considerations in patients with mitochondrial defects.

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Mitochondrial diseases are increasingly recognized causes of neurologic, cardiac, muscle, and endocrine disorders.
• High-energy tissues like the brain, heart, and muscles are most vulnerable to mitochondrial dysfunction.
• These diseases manifest with varied symptoms including encephalopathies, cardiomyopathies, and myopathies.

Purpose of the Study:

• To review critical considerations for managing patients with mitochondrial disease.
• To highlight the challenges posed by anesthesia and metabolic stress in these patients.
• To emphasize the need for careful perioperative care.

Main Methods:

• Review of current medical literature on mitochondrial disease and patient management.
• Analysis of potential risks associated with anesthesia and surgical procedures.
• Discussion of metabolic stressors like fasting and catabolism.

Main Results:

• Mitochondrial diseases are complex, with hundreds of genetic and environmental causes.
• Anesthetics can pose risks by inhibiting metabolism in patients with mitochondrial disease.
• Fasting, catabolism, and pain can exacerbate the biochemical stress in affected individuals.

Conclusions:

• Careful perioperative management is crucial for patients with mitochondrial disease.
• Understanding anesthetic risks and metabolic vulnerabilities is essential for physician decision-making.
• Improved diagnosis and treatment allow more patients to undergo necessary procedures, necessitating specialized care protocols.